Method using enteric-coated etidronate for treating calcification, hypercalcaemia, and calcinosis of the brain and other organs
AssigneeZy Ytherapeutics LLC
InventorsBryan Alan Hill, John Stephan McCarty, Jeffrey Arlin Loeb
Life of this patent
Estimating the term…
Abstract
Among other things, compositions, kits, and methods for epilepsy therapy using a process for treating calcinosis manifested in Neurocysticercosis, Tuberous Sclerosis Complex, and Sturge-Weber Syndrome; an automated platform for real-time diagnosis and treatment of calcinosis comprising a computer-implemented method for using predictive analytics for administering a novel drug, Kamini™, to human patients generated at least in part from information that has been accumulated automatically from on-line resources.
Claims15
A method for treating a neurological condition produced by calcinosis in a human patient, the method comprising:
- (a) diagnosing the calcinosis by means of a real-time, interactive medical intelligence system;
- (b) devising a drug regimen by means of a real-time, interactive, computer-implemented medical intelligence system;
- (c) administering at least one pharmaceutically effective dose according to said drug regimen;
- (d) monitoring the realization of symptom relief;
- (e) obtaining auxiliary medical information for effectiveness;
- (f) revising the said drug regimen to deal with side effects;
- (g) adjusting the said drug regimen to optimize symptom relief;
- (h) obtaining a long-term treatment drug regimen adjusted for optimized symptom relief.
A kit for treating a calcinosis-induced epilepsy in a human patient, the kit comprising:
- (a) a drug composition comprising an enteric-coated bisphosphonate;
- (b) instructions for use of the drug composition;
- and
- (c) a delayed release, enteric-coated tablet;
- (d) a non-transitory computer readable medium storing instructions for causing a computing system to provide medical guidance.
A product containing a composition for treating calcinosis-induced epilepsy, the composition comprising a bisphosphonate and a PH-mediated polymer designed to perforate and open at the best time so as to maximize absorption of the treatment via extended release.
Dependencies are inferred from the claim text.